This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
IntroductionThis paper aims to expose the link between occupational exposure to respirable crystalline silica (SiO2) and cardiovasculardiseases (CVDs).MethodsA Specific cardiovasculardiseases, such as acute myocardialinfarction, arrhythmias, pulmonary hypertension and pericarditis, were also pointed.
Background Observational studies have reported that sleep is associated with the risk of major depressive disorder (MDD) and cardiovasculardiseases (CVDs). However, the causal relationships among various sleep traits remain contentious, and whether MDD mediates the impact of specific sleep traits on CVDs is unclear.
There are several factors which increase the risk of cardiovasculardisease in survivors of spinal cord injury. Higher risk of myocardialinfarction, heart failure and atrialfibrillation was noted in spinal cord injury survivors compared to controls. Survivors with severe disability had the highest risk.
BackgroundRecent evidence highlights an increasing incidence of myocardialinfarction in young women. years]) admitted to the China Chest Pain Center Database between 2016 and 2021.
Background and aims It is uncertain if there is a link between non-alcoholic fatty liver disease (NAFLD) and cardiovasculardiseases (CVD) in young adults and children. Further subgroup analyses showed that individuals with NAFLD were at a heightened risk of coronary heart disease (CHD) (HR = 3.10, 95% CI: 2.01–4.77,
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovasculardiseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
Background:Cancer and obstructive sleep apnea (OSA) individually elevate cardiovasculardiseases (CVD) and stroke risk. Adverse CVD outcomes was defined as a composite of incident heart failure, incident atrialfibrillation / flutter, incident myocardialinfarction or all-cause mortality.
BACKGROUND:Clonal hematopoiesis of indeterminate potential (CHIP), a common age-associated phenomenon, associates with increased risk of both hematological malignancy and cardiovasculardisease.
In this week’s View, Dr. Eagle covers opportunities in the postpartum period to reduce cardiovasculardisease risk after adverse pregnancy outcomes. He then explores the apparent increased risk of myocardialinfarction, heart failure and atrialfibrillation after spinal cord injury.
Prolonged ambulatory ECG monitoring, commonly referred to as Holter testing, increases the chance of detecting abnormalities responsible for the symptoms of cardiovasculardiseases, especially those whose pathognomonic symptoms occur only periodically. AFIB/AFL – atrialfibrillation or atrial flutter episodes.
Dysregulation of miR1 has been associated with various heart diseases, where a significant reduction (>75%) in miR1 expression has been observed in patient hearts with atrialfibrillation or acute myocardialinfarction.
Recommendation from UK National Institute for Health and Care Excellence is that people with or at high risk of cardiovasculardisease consume at least one portion of oily fish a week. The authors reported that the regular use of fish oil supplements might be a risk factor for atrialfibrillation among general population.
In the setting of arrhythmias, specific SDoHs can increase the incidence of atrialfibrillation and adversely affect major outcomes in these patients. In congenital heart diseases, SDoHs can affect major outcomes, as well. In congenital heart diseases, SDoHs can affect major outcomes, as well.
While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovasculardiseases, the world’s leading cause of death.
BackgroundThere are few data on sex differences in the association between schizophrenia and the development of cardiovasculardisease (CVD). The primary end point is defined as a composite end point that includes myocardialinfarction, angina pectoris, stroke, heart failure, atrialfibrillation, and pulmonary thromboembolism.
Left ventricular (LV) global longitudinal strain (GLS) assessed via feature tracking cardiac magnetic resonance imaging is associated with increased risk of major adverse cardiovascular events (MACE). LV GLS is associated with MACE in adults without prevalent cardiovasculardisease (CVD). 2.38, p = 0.04).
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF). link] ACC/AHA Release Updated AtrialFibrillation Guidelines for 2023. million. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.
Objective Historical reductions in cardiovasculardisease (CVD) due to lifestyle and treatment improvements are now threatened by factors such as increasing obesity and diabetes, but the relative importance of different risk factors varies by CVD condition.
By quantifying the ratio of left atrial to left ventricular end-diastolic volumes, LACI offers unprecedented prognostic insights into a wide range of cardiovasculardiseases, including atrialfibrillation, heart failure, and myocardialinfarction, as well as other conditions such as hypertension and cardiomyopathies.
History of Cardiovasculardisease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. to 1.64) for myocardialinfarction or death from coronary heart disease, and 1.06 (95 percent confidence interval, 0.77 Old myocardialinfarction, 6.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content